This company listing is no longer active
Laboratory Corporation of America Holdings Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Laboratory of America Holdings has been growing earnings at an average annual rate of 15.8%, while the Healthcare industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 9.1% per year. Laboratory of America Holdings's return on equity is 9.7%, and it has net margins of 6.8%.
Belangrijke informatie
15.8%
Groei van de winst
17.6%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | 9.1% |
Rendement op eigen vermogen | 9.7% |
Nettomarge | 6.8% |
Volgende winstupdate | 27 Jul 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Laboratory Corporation of America Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
31 Mar 23 | 14,755 | 1,000 | 2,089 | 0 |
31 Dec 22 | 14,877 | 1,279 | 2,000 | 0 |
30 Sep 22 | 15,259 | 1,756 | 1,912 | 0 |
30 Jun 22 | 15,715 | 1,991 | 1,922 | 0 |
31 Mar 22 | 15,859 | 2,099 | 1,986 | 0 |
31 Dec 21 | 16,121 | 2,377 | 1,952 | 0 |
30 Sep 21 | 16,555 | 2,763 | 1,894 | 0 |
30 Jun 21 | 16,388 | 2,879 | 1,787 | 0 |
31 Mar 21 | 15,316 | 2,643 | 1,718 | 0 |
31 Dec 20 | 13,979 | 1,556 | 1,729 | 0 |
30 Sep 20 | 12,442 | 845 | 1,550 | 0 |
30 Jun 20 | 11,475 | 362 | 1,535 | 0 |
31 Mar 20 | 11,587 | 321 | 1,523 | 0 |
31 Dec 19 | 11,555 | 824 | 1,625 | 0 |
30 Sep 19 | 11,389 | 755 | 1,521 | 0 |
30 Jun 19 | 11,292 | 853 | 1,496 | 0 |
31 Mar 19 | 11,276 | 896 | 1,490 | 0 |
31 Dec 18 | 11,333 | 884 | 1,578 | 0 |
30 Sep 18 | 11,291 | 1,414 | 1,504 | 0 |
30 Jun 18 | 11,081 | 1,266 | 1,483 | 0 |
31 Mar 18 | 10,743 | 1,217 | 1,458 | 0 |
31 Dec 17 | 10,308 | 1,227 | 1,499 | 0 |
30 Sep 17 | 9,951 | 724 | 1,436 | 0 |
30 Jun 17 | 9,702 | 732 | 1,471 | 0 |
31 Mar 17 | 9,556 | 751 | 1,522 | 0 |
31 Dec 16 | 9,553 | 712 | 1,306 | 0 |
30 Sep 16 | 9,295 | 658 | 1,592 | 0 |
30 Jun 16 | 9,192 | 633 | 1,652 | 0 |
31 Mar 16 | 9,029 | 599 | 1,556 | 0 |
31 Dec 15 | 8,506 | 438 | 1,469 | 0 |
30 Sep 15 | 7,774 | 447 | 1,360 | 0 |
30 Jun 15 | 7,056 | 430 | 1,213 | 0 |
31 Mar 15 | 6,353 | 401 | 1,204 | 0 |
31 Dec 14 | 6,012 | 511 | 1,181 | 0 |
30 Sep 14 | 5,936 | 518 | 1,164 | 0 |
30 Jun 14 | 5,846 | 529 | 1,143 | 0 |
31 Mar 14 | 5,798 | 540 | 1,131 | 0 |
31 Dec 13 | 5,808 | 574 | 1,129 | 0 |
30 Sep 13 | 5,777 | 568 | 1,122 | 0 |
30 Jun 13 | 5,734 | 567 | 1,118 | 0 |
31 Mar 13 | 5,689 | 569 | 1,117 | 0 |
31 Dec 12 | 5,671 | 583 | 1,105 | 0 |
30 Sep 12 | 5,632 | 598 | 1,096 | 0 |
Kwaliteitswinsten: LH.WI has a large one-off loss of $381.4M impacting its last 12 months of financial results to March 31 2023.
Groeiende winstmarge: LH.WI's current net profit margins (6.8%) are lower than last year (13.2%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: LH.WI's earnings have grown by 15.8% per year over the past 5 years.
Versnelling van de groei: LH.WI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: LH.WI had negative earnings growth (-52.3%) over the past year, making it difficult to compare to the Healthcare industry average (-9.8%).
Rendement op eigen vermogen
Hoge ROE: LH.WI's Return on Equity (9.7%) is considered low.